ストックスクリーナーアプリを入手
1.26
3.70%
0.045
アフターアワーズ：
1.27
0.01
+0.79%
前日終値:
$1.215
開ける：
$1.23
24時間の取引高:
189.82K
Relative Volume:
0.54
時価総額：
$67.20M
収益：
-
当期純損益:
$-78.34M
株価収益率:
-0.8503
EPS:
-1.4819
ネットキャッシュフロー:
$-75.02M
1週間 パフォーマンス:
+5.88%
1か月 パフォーマンス:
-11.27%
6か月 パフォーマンス:
+13.51%
1年 パフォーマンス:
-18.71%
1日の値動き範囲:
$1.215
$1.285
1週間の範囲:
$1.16
$1.33
52週間の値動き範囲:
$1.02
$1.88
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
名前
Pmv Pharmaceuticals Inc
セクター
電話
(609) 642-6670
住所
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP vs VRTX, REGN, ARGX, RVMD, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.26 | 67.20M | 0 | -78.34M | -75.02M | -1.4819 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-08 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-05-13 | 開始されました | Craig Hallum | Buy |
| 2024-04-12 | 開始されました | Jefferies | Buy |
| 2023-12-27 | 開始されました | Ladenburg Thalmann | Buy |
| 2022-03-02 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-09-22 | アップグレード | Goldman | Neutral → Buy |
| 2021-08-19 | 開始されました | Oppenheimer | Perform |
| 2021-08-02 | 開始されました | Guggenheim | Buy |
| 2021-07-29 | 開始されました | H.C. Wainwright | Buy |
| 2020-10-20 | 開始されました | BofA Securities | Buy |
| 2020-10-20 | 開始されました | Cowen | Outperform |
| 2020-10-20 | 開始されました | Evercore ISI | Outperform |
| 2020-10-20 | 開始されました | Goldman | Neutral |
すべてを表示
Pmv Pharmaceuticals Inc (PMVP) 最新ニュース
PMV Pharmaceuticals (NASDAQ:PMVP) Posts Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Pmv Pharmaceuticals Inc (NASDAQ: PMVP) Share Price, PMVP Stock News, PMVP Share Price & Updates - Kalkine
PMV Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet
Form 8K Pmv Pharmaceuticals Inc For: 14 August By Investing.com - Investing.com Nigeria
PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights - The Manila Times
PMV Pharma Reports $18.1 Million Second-Quarter Net Loss - quiverquant.com
PMV Pharmaceuticals (PMVP) flags going-concern risk as rezatapopt advances toward NDA - Stock Titan
PMVP: Net loss narrowed, but liquidity concerns persist as rezatapopt advances toward NDA submission - TradingView
Ovarian cancer drug trial completes enrollment; PMV plans 2027 filing - Stock Titan
PMV Pharmaceuticals Inc (PMVP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PMVP Q2'26 Earnings: EPS estimate is (0.39) USD - TradingView
PMV Pharmaceuticals Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
PMV Pharmaceuticals Inc (PMVP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Eversept Partners LP Invests $2.91 Million in PMV Pharmaceuticals, Inc. $PMVP - MarketBeat
PMV Pharmaceuticals Inc (PMVP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PMV Pharmaceuticals Inc (PMVP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PMV Pharmaceuticals Inc (PMVP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PMV Pharmaceuticals Inc (PMVP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PMVP|PMV Pharmaceuticals Inc|Price:1.140|Chg%:+0.020 - TradingKey
PMV Pharmaceuticals Inc (PMVP) Earnings Date & Reports & Earnings News - TradingKey
TradingKey - TradingKey
PMV Pharmaceuticals Inc (PMVP) Valuation: PE, PB & Fair Value Analysis - TradingKey
PMV Pharmaceuticals Inc (PMVP) Institutional Confidence - TradingKey
PMV Pharmaceuticals Inc (PMVP) Income Statement - TradingKey
PMVP|PMV Pharmaceuticals Inc|Price:1.240|Chg%:-0.090 - TradingKey
PMV Pharmaceuticals Inc (PMVP) Cash Flow - TradingKey
PMV Pharmaceuticals Inc (PMVP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PMVP|PMV Pharmaceuticals Inc|Price:1.180|Chg%:-0.060 - TradingKey
PMV Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:PMVP - TradingView
ArrowMark Colorado Holdings LLC Reduces Stake in PMV Pharmaceuti - GuruFocus
ArrowMark Colorado Holdings LLC Reduces Stake in PMV Pharmaceuticals Inc - GuruFocus
PMV Pharmaceuticals (PMVP) Declines 7.86% as Stock Tests Key Support LevelsVolatility Skew - dars.gov.et
PMV Pharmaceuticals (PMVP) Holds Steady at $1.42 as Trading Range TightensValue Area High - dars.gov.et
RANI Stock Price and Chart — NASDAQ:RANI - TradingView
PMV Pharmaceuticals (PMVP) Holds Steady Near Support as Consolidation ContinuesStraddle Setup - DonanımHaber
ArrowMark Colorado Holdings (PMVP) holds 3.67% stake in PMV Pharmaceuticals - Stock Titan
PMV Pharmaceuticals Coverage Assumed by Ladenburg Thalmann at Buy - Moomoo
PMV Pharmaceuticals Price Target Announced at $3.00/Share by Ladenburg Thalmann - Moomoo
PMV Pharmaceuticals outlines its cancer drug pipeline as shares trade quietly - Ad-hoc-news.de
PMV Pharmaceuticals (PMVP) upgraded to buy: Here's why - MSN
PMV Pharmaceuticals holds the focus as investors await the next catalyst. - Ad-hoc-news.de
July 2026's Spotlight On Promising Penny Stocks - Sahm
Enterprise value to EBITDA forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Price to earnings forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Enterprise value to revenue forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Price to book forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Enterprise value to EBIT forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
PMV Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:PMVP) - TradingView
PMVP Forecast — Price Target — Prediction for 2027 - TradingView
PMV Pharmaceuticals (PMVP) Upgraded to Buy: Here's Why - Yahoo Finance
PMVP Q1 2026 Earnings: Narrower-Than-Expected Loss Mitigates Stock DeclineEarnings Risk Report - newsline.com
Pmv Pharmaceuticals Inc (PMVP) 財務データ
収益
当期純利益
現金流量
EPS
0.52%
0.07%
大文字化:
|
ボリューム (24 時間):